After seeing some success around a treatment for epilepsy, the cannabis industry is increasingly eyeing for products for people with the autism spectrum disorder.
Autism is a lifelong developmental disorder that affects communication, behavior and the ability to socialize. As many as one in 54 children are currently diagnosed with autism, according to Centers for Disease Control, and so are millions of adults.
In addition to companies looking expand their customer base and come up with new treatments, the Autism Science Foundation is also urging further study on the safety and efficacy of medical marijuana in autism.
MORE…
Author: Canan Schuman, PharmD/PhD
Canan Schumann is Chief Editor for Axxiem and for Axxiem's blog "BiotechOntheWeb". When not writing for Axxiem, Canan works as a Clinical Research Scientist II at the Research and Development Department at Molecular Testing Labs, developing endpoint assays for the detection of infectious disease and cancer. Canan currently resides in Portland, Oregon, where he received his Honors Bachelor of Science (HBS), Doctor of Pharmacy (PharmD.), and his Doctor of Philosophy (Ph.D.) in Biopharmaceutics at Oregon State University.